Genmab A/S (GNMSF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 03:37PM EDT. Market open.
| Previous close | 272.81 |
| Open | 272.81 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 272.81 - 272.81 |
| 52-week range | 262.00 - 426.50 |
| Volume | |
| Avg. volume | 1,009 |
| Market cap | 18.176B |
| Beta (5Y monthly) | 0.78 |
| PE ratio (TTM) | 28.75 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Comstock Inc (LODE) Q1 2024 Earnings Call Transcript Highlights: Strategic Investments and ...
Explore key insights from Comstock Inc's Q1 2024 earnings, including significant revenue streams, strategic investments, and future financial strategies.
- Investor's Business Daily
Genmab Takes The Next Step In Its 'Evolution' With A $1.8 Billion Takeover
Genmab stock slumped Wednesday after the Danish biotech announced it will buy privately held ProfoundBio for $1.8 billion.
- Insider Monkey
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
© 2024 Yahoo. All rights reserved.